Commonwealth Equity Services Inc increased its position in Medical Properties Trust, Inc. (NYSE:MPW) by 17.0% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 90,584 shares of the real estate investment trust’s stock after purchasing an additional 13,162 shares during the period. Commonwealth Equity Services Inc’s holdings in Medical Properties Trust were worth $1,189,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. raised its stake in Medical Properties Trust by 6.6% during the 2nd quarter. Vanguard Group Inc. now owns 57,790,855 shares of the real estate investment trust’s stock valued at $743,768,000 after acquiring an additional 3,561,518 shares during the last quarter. Bank of New York Mellon Corp raised its stake in Medical Properties Trust by 9.5% during the 3rd quarter. Bank of New York Mellon Corp now owns 14,803,927 shares of the real estate investment trust’s stock valued at $194,375,000 after acquiring an additional 1,278,480 shares during the last quarter. Principal Financial Group Inc. raised its stake in Medical Properties Trust by 1.5% during the 3rd quarter. Principal Financial Group Inc. now owns 12,037,765 shares of the real estate investment trust’s stock valued at $158,057,000 after acquiring an additional 178,569 shares during the last quarter. LSV Asset Management raised its stake in Medical Properties Trust by 11.9% during the 2nd quarter. LSV Asset Management now owns 5,666,676 shares of the real estate investment trust’s stock valued at $72,930,000 after acquiring an additional 601,200 shares during the last quarter. Finally, Prudential Financial Inc. raised its stake in Medical Properties Trust by 28.7% during the 3rd quarter. Prudential Financial Inc. now owns 5,562,595 shares of the real estate investment trust’s stock valued at $73,037,000 after acquiring an additional 1,241,797 shares during the last quarter. 84.31% of the stock is owned by institutional investors and hedge funds.

MPW has been the topic of several recent analyst reports. KeyCorp reiterated a “hold” rating on shares of Medical Properties Trust in a research report on Sunday, September 17th. Zacks Investment Research cut Medical Properties Trust from a “buy” rating to a “hold” rating in a research report on Wednesday, August 2nd. ValuEngine cut Medical Properties Trust from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. Jefferies Group LLC reiterated a “buy” rating and set a $15.00 target price on shares of Medical Properties Trust in a research report on Tuesday, August 29th. Finally, SunTrust Banks, Inc. reiterated a “buy” rating and set a $15.00 target price on shares of Medical Properties Trust in a research report on Friday, November 3rd. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and seven have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $14.18.

Medical Properties Trust, Inc. (MPW) traded down $0.03 during midday trading on Monday, reaching $13.80. The company’s stock had a trading volume of 634,200 shares, compared to its average volume of 3,172,649. The company has a debt-to-equity ratio of 1.26, a current ratio of 2.55 and a quick ratio of 2.55. Medical Properties Trust, Inc. has a 52 week low of $11.57 and a 52 week high of $14.22. The firm has a market cap of $5,025.35, a PE ratio of 10.70, a price-to-earnings-growth ratio of 2.03 and a beta of 0.95.

Medical Properties Trust (NYSE:MPW) last released its earnings results on Thursday, November 2nd. The real estate investment trust reported $0.33 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.32 by $0.01. The company had revenue of $176.60 million for the quarter, compared to analysts’ expectations of $172.57 million. Medical Properties Trust had a return on equity of 7.36% and a net margin of 39.95%. The firm’s quarterly revenue was up 39.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.30 EPS. research analysts predict that Medical Properties Trust, Inc. will post 1.32 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 11th. Investors of record on Thursday, December 7th will be issued a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a dividend yield of 6.96%. The ex-dividend date is Wednesday, December 6th. Medical Properties Trust’s dividend payout ratio is currently 126.32%.

COPYRIGHT VIOLATION NOTICE: “Commonwealth Equity Services Inc Boosts Stake in Medical Properties Trust, Inc. (MPW)” was first posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/commonwealth-equity-services-inc-boosts-stake-in-medical-properties-trust-inc-mpw/1729181.html.

About Medical Properties Trust

Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.

Want to see what other hedge funds are holding MPW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medical Properties Trust, Inc. (NYSE:MPW).

Institutional Ownership by Quarter for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.